Marc Tessier-Lavigne Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Marc Tessier-Lavigne.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Marc Tessier-Lavigne. Marc Tessier-Lavigne is a EVP, RESEARCH DRUG DISCOVERY in GENENTECH INC ($DNA) and a Director in PFIZER INC ($PFE) and a Director in REGENERON PHARMACEUTICALS INC ($REGN) and a Director in AGIOS PHARMACEUTICALS INC ($AGIO) and a Director in Juno Therapeutics, Inc. ($JUNO) and a Director in Denali Therapeutics Inc. ($DNLI).
Address: 1 DNA WAY SO SAN FRANCISCO 94080 CA
Companies in which Marc Tessier-Lavigne is an Insider
AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 23 2016
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Denali Therapeutics Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Marc Tessier-Lavigne: Director
Holdings: 2,544,370 shares
Latest Transaction: Jun 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENENTECH INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: EVP, RESEARCH DRUG DISCOVERY
Holdings: 0 shares
Latest Transaction: Mar 30 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Juno Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Marc Tessier-Lavigne: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 21 2016
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PFIZER INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 24 2015
$PFE Market Capitalization: $195.04B
$PFE Previous Close: $32.08
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REGENERON PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Tessier-Lavigne: Director
Holdings: 2,078 shares
Current Value: $743,280
Latest Transaction: Jan 05 2021
$REGN Market Capitalization: $37.03B
$REGN Previous Close: $357.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Marc Tessier-Lavigne
Sentiment: All, AGIO, DNLI, DNA, JUNO, PFE, REGN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 63.76 | 6,222 | 396,715 | 6,222 | |
| Jun 04 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Grant | A | 0.00 | 2,074 | 0 | 2,544,370 | 2.5 M to 2.5 M (+0.08 %) |
| May 24 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 60.03 | 8,806 | 528,580 | 2,542,296 | 2.6 M to 2.5 M (-0.35 %) |
| May 24 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 60.13 | 37,957 | 2,282,468 | 2,551,102 | 2.6 M to 2.6 M (-1.47 %) |
| Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 71.35 | 1,031 | 73,563 | 2,642,296 | 2.6 M to 2.6 M (-0.04 %) |
| Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 69.59 | 3,482 | 242,309 | 2,643,327 | 2.6 M to 2.6 M (-0.13 %) |
| Mar 03 2021 | DNLI | Denali Therapeutic ... | Tessier-Lavigne Marc | Director | Sell | S | 68.50 | 6,011 | 411,778 | 2,646,809 | 2.7 M to 2.6 M (-0.23 %) |